Differences in tumor regulatory T-cell localization and activation status impact patient outcome

Cancer Research

Volumn 69, Issue 20, 2009, Pages 7895-7898

  Ménétrier Caux, Christine ^a,b,c,d   Gobert, Michael ^a,b,c,d   Caux, Christophe ^a,b,c,d  

^a INSERM   (France)

^b CENTRE LÉON BÉRARD   (France)

^c UNIVERSITÉ LYON 1   (France)

^d EA 1892   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; MACROPHAGE DERIVED CHEMOKINE;

BREAST CARCINOMA; CELLULAR DISTRIBUTION; DENDRITIC CELL; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SURVIVAL; T LYMPHOCYTE ACTIVATION; TUMOR LOCALIZATION;

HUMANS; LYMPHOCYTE ACTIVATION; NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 70350238332     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1642     Document Type: Review

References (33)

1. + phenotypes. Int J Cancer 2004;110:710-720
2. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313:1960-1964 (Pubitemid 44498003)
3. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006;6:295-307.
4. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-949 (Pubitemid 39273735)
5. Gao Q, Qiu SJ, Fan J, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007;25:2586-2593 (Pubitemid 47041232)
6. Kobayashi N, Hiraoka N, Yamagami W, et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 2007;13:902-911 (Pubitemid 46340366)
7. + regulatory T cells is associated with clinical behaviour in gastric cancer. Br J Cancer 2008;98:148-153
8. + regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 2006;107:2866-2872
9. + T-cell subpopulations in head and neck cancers. Clin Cancer Res 2006;12:465-472
10. + T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009;27:186-192
11. + regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 2008;93:193-200.
12. Camus M, Tosolini M, Mlecnik B, et al. Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Cancer Res 2009;69:2685-2693
13. Fox SB, Launchbury R, Bates GJ, et al. The number of regulatory T cells in prostate cancer is associated with the androgen receptor and hypoxia-inducible factor (HIF)-2alpha but not HIF-1alpha. Prostate 2007;67:623-629 (Pubitemid 46685282)
14. Grabenbauer GG, Lahmer G, Distel L, Niedobitek G. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clin Cancer Res 2006;12:3355-3360 (Pubitemid 43910879)
15. Ling KL, Pratap SE, Bates GJ, et al. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun 2007;7:7.
16. Dieu Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008;26:4410-4417
17. Bates GJ, Fox SB, Han C, et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk for late relapse. J Clin Oncol 2006;24:5373-5380 (Pubitemid 46623168)
18. Gobert M, Treilleux I, Bendriss-Vermare N, et al. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 2009;69:2000-2009
19. (+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 2007;204:1335-1347
20. Mariani M, Lang R, Binda E, Panina-Bordignon P, D'Ambrosio D. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells. Eur J Immunol 2004;34:231-240 (Pubitemid 38111539)
21. Treilleux I, Blay JY, Bendriss-Vermare N, et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res 2004;10:7466-7474 (Pubitemid 39561754)
22. Belkaid Y, Oldenhove G. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 2008;29:362-371
23. (+) regulatory t cells in human thymus and periphery. Immunity 2008;28:870-880
24. (high) regulatory T cells are over-represented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 2004;173:1444-1453
25. Wang HY, Peng G, Guo Z, Shevach EM, Wang RF. Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells. J Immunol 2005;174:2661-2670 (Pubitemid 40279680)
26. + regulatory T cells specific for human papillomavirus antigens. Proc Natl Acad Sci U S A 2007;104:12087-12092
27. Palucka AK, Ueno H, Fay JW, Banchereau J. Taming cancer by inducing immunity via dendritic cells. Immunol Rev 2007;220:129-150 (Pubitemid 350045575)
28. Burmeister Y, Lischke T, Dahler AC, et al. ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol 2008;180:774-782
29. Gotsman I, Grabie N, Gupta R, et al. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 2006;114:2047-2055 (Pubitemid 44706881)
30. + T regulatory cells: implications and impact on tumor-mediated immune suppression. J Immunol 2008;180:2967-2980
31. Wolchok JD, Saenger Y. The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation. Oncologist 2008;13:2-9.
32. + T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 2007;13:2075-2081
33. Carreras J, Lopez-Guillermo A, Fox BC, et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006;108:2957-2964 (Pubitemid 44776932)